抑郁症患者情绪词识别对照研究

目的：探讨抑郁症患者和正常对照者在进行情绪词识别时的差异。方法：34例在4周内未用药的抑郁症患者和32名正常对照者进行情绪词识别Go/No-Go测验。结果：抑郁症患者正情绪词识别时,反应时显著长于负性情绪词和正常对照组,遗漏数显著多于负性词和正常对照组。结论：抑郁症患者存在负性情绪偏好。     

Virome of Ixodes ricinus,Dermacentor reticulatus,and Haemaphysalis concinna Ticks from Croatia

Tick-borne diseases are a serious threat to both public and veterinary health. In this study, we used high-throughput sequencing to characterize the virome of three tick species implicated in the spread of vector-borne disease throughout Croatia. Ten viruses were identified, including seven potential novel species within the viral families Flaviviridae, Nyamiviridae, Rhabdoviridae, Peribunyaviridae, Phenuiviridae, and Nairoviridae.     

Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study

The phosphatidylinositol‐3‐kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway is frequently activated in HER2‐negative breast cancer and may play a role in taxane resistance. The phase IB/II TAKTIC trial ({"type":"clinical-trial","attrs":{"text":"NCT01980277","term_id":"NCT01980277"}}NCT01980277) has shown that combining a dual AKT and p70 ribosomal protein S6 kinase (p70S6K) inhibitor (LY2780301) taken orally with weekly paclitaxel in HER2‐negative advanced breast cancer is feasible, with preliminary evidence of efficacy. We wanted to explore whether circulating tumor DNA (ctDNA) may be a surrogate marker of treatment efficacy in this setting. Serial plasma samples were collected and cell‐free DNA was sequenced using low‐coverage whole‐genome sequencing, and analysis was completed with droplet digital polymerase chain reaction (PCR) for some patients with driver mutations. Baseline tumor fraction (TF) and TF after 7 weeks on treatment were compared to progression‐free survival (PFS) and the overall response rate. We also explored circulating copy number alterations associated with treatment failure. Of the 51 patients enrolled in the TAKTIC trial, at least one plasma sample was available for 44 cases (96 timepoints). All patients with tumor TP53, PI3KCA, or AKT1 mutations harbored at least one of these alterations in plasma. TF at inclusion was correlated with PFS (6m‐PFS was 92% for ctDNAneg patients vs 68% for ctDNApos cases; hazard ratio [HR] = 3.45, 95% confidence interval [CI] [1.34–8.90], P = 0.007). ctDNA status at week 7 was not correlated with prognosis. Even though most circulating copy number alterations were conserved at disease progression, some genomic regions of interest were altered in post‐progression samples. In conclusion, ctDNA detection at baseline was associated with shorter PFS in patients included in the TAKTIC trial. Plasma‐based copy number analysis may help to identify alterations involved in resistance to treatment.     

Pivoting Novel Exosome-Based Technologies for the Detection of SARS-CoV-2

The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx) initiative to meet the needs for COVID-19 diagnostic and surveillance testing, and to speed its innovation in the development, commercialization, and implementation of new technologies and approaches. The RADx Radical (RADx-Rad) initiative is one component of the NIH RADx program which focuses on the development of new or non-traditional applications of existing approaches, to enhance their usability, accessibility, and/or accuracy for the detection of SARS-CoV-2. Exosomes are a subpopulation of extracellular vesicles (EVs) 30–140 nm in size, that are critical in cell-to-cell communication. The SARS-CoV-2 virus has similar physical and molecular properties as exosomes. Therefore, the novel tools and technologies that are currently in development for the isolation and detection of exosomes, may prove to be invaluable in screening for SARS-CoV-2 viral infection. Here, we describe how novel exosome-based technologies are being pivoted for the detection of SARS-CoV-2 and/or the diagnosis of COVID-19. Considerations for these technologies as they move toward clinical validation and commercially viable diagnostics is discussed along with their future potential. Ultimately, the technologies in development under the NIH RADx-Rad exosome-based non-traditional technologies toward multi-parametric and integrated approaches for SARS-CoV-2 program represent a significant advancement in diagnostic technology, and, due to a broad focus on the biophysical and biochemical properties of nanoparticles, the technologies have the potential to be further pivoted as tools for future infectious agents.     

Surgical Management for Chronic Destructive Septic Hip Arthritis: Debridement,Antibiotics, and Single‐Stage Replacement is as Effective as Two‐Stage Arthroplasty

ObjectiveTo compare the surgical outcomes of debridement, antibiotics, and single‐stage total hip replacement (DASR) vs two‐stage arthroplasty (two‐stage arthroplasty) for chronic destructive septic hip arthritis (SHA).MethodsCases of chronic destructive SHA treated by DASR or two‐stage arthroplasty in our department from January 2008 to October 2021 were retrospectively reviewed. Patient demographic information, perioperative inflammation markers, intraoperative blood loss, microbial culture, and metagenomic new generation sequencing results were recorded. The perioperative complications, hospital stay, hospitalization cost, infection recurrence rate, and Harris Hip Score (HHS) at the last follow‐up were compared between the two groups.ResultsA total of 28 patients were included in the study, including 11 patients who received DASR and 17 patients who received two‐stage arthroplasty. There was no significant difference in demographic information, preoperative serum inflammatory markers, synovial fluid white blood cell count, or percentage of polymorphonuclear leukocytes between the two groups. The DASR group demonstrated significantly lower intraoperative blood loss [(368.2 ± 253.3) mL vs (638.2 ± 170.0) mL, p = 0.002], hospital stay [(22.6 ± 8.1) days vs (43.5 ± 13.2) days, p < 0.0001], and hospitalization expenses [(81,269 ± 11,496) RMB vs (137,524 ± 25,516) RMB, p < 0.0001] than the two‐stage arthroplasty group. In the DASR group, one patient had dislocation as a complication. There were no cases with recurrence of infection. In the two‐stage arthroplasty group, there was one case complicated with spacer fracture, one case with spacer dislocation, and one case with deep vein thrombosis of the lower limbs. There were no cases with recurrence of infection. There were no significant differences in the readmission rate, complication rate, or HHS at the last follow‐up between the two groups.ConclusionsBoth DASR and two‐stage arthroplasty achieved a satisfactory infection cure rate and functional recovery for chronic destructive SHA, and DASR demonstrated significantly lower intraoperative blood loss, hospital stay, and hospitalization costs than two‐stage arthroplasty. For appropriately indicated patients, if microbial data are available and a standardized debridement protocol is strictly followed, DASR can be a treatment option.     

星点设计-效应面法优化炒茺蔚子炮制工艺

目的:利用星点设计-效应面法对炒茺蔚子的炮制工艺进行优化,为炒茺蔚子的规范化生产提供依据。方法:采用清炒法,以炮制温度、炮制时间、炒药机转速为自变量,总生物碱、盐酸水苏碱、水溶性浸出物、醇溶性浸出物质量分数为评价指标,对自变量各水平进行多元回归拟合,利用效应面法筛选最佳炮制工艺并进行预测分析。采用UV测定总生物碱的含量,检测波长520 nm;采用高效液相色谱仪-蒸发光散射法测定盐酸水苏碱的含量,流动相乙腈-水(60∶40),流速0.5 m L·min~(-1),漂移管温度70℃。结果:三项式拟合复合相关系数较高。最佳炮制工艺为炮制温度219℃,炮制时间2 min,炒药机转速14 r·min~(-1)。总生物碱、盐酸水苏碱、水溶性浸出物、醇溶性浸出物质量分数的平均值分别为9.82,2.50,86.16,193.28 mg·g~(-1),综合评分与三项式拟合方程预测值偏差0.87%。结论:利用星点设计-效应面法优化炒茺蔚子炮制工艺的方法简便且预测性良好,适用于炒茺蔚子的规范化生产。     

利咽润喉含片的制备与质量控制

目的：对利咽润喉含片的制备工艺和质量标准进行研究。方法：采用水提、喷雾干燥法制备利咽润喉含片;采用化学方法对游离羟基蒽醌、薄层色谱法对大黄素和熊果酸分别进行定性鉴别;采用HPLC法对虎杖中大黄素进行定量分析,色谱柱为Hedera ODS-2 C18（250 mm×4.6 mm,5μm）,流动相为甲醇-水（78∶22）,流速为1.0 mL·min-1,检测波长为254 nm。结果：制备工艺简便可行;薄层色谱斑点清晰,专属性强;大黄素进样量在0.204-2.04μg范围内线性关系良好（r=1.0000）,平均回收率为99.61%,RSD%为0.78%。结论：所建立的定性定量方法简便、准确、重复性好,可作为利咽润喉含片的质量控制方法。     

正交试验优选黑骨藤的超声提取工艺研究

目的 研究黑骨藤的最佳提取工艺.方法 以杠柳苷提取率为指标,采用正交试验优选提取工艺参数.结果 最佳工艺条件:溶剂为50％乙醇,料液比1∶15,功率800 W,温度50℃,提取2次,每次20 min.结论 此工艺合理可行,适用于黑骨藤中杠柳苷的提取.